Prevalence, risk factors, and treatment methods of thirst in critically ill patients: A systematic review and meta-analysis
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0315500 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2025. Verfasst von Takuto Fukunaga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Critical Illness, Thirst. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Critically ill patients admitted to the intensive care unit (ICU) experience various symptoms and discomfort. Although thirst is a typical distressing symptom and should be assessed daily, it is crucial to understand its prevalence and risk factors in the ICU setting. Nevertheless, currently, systematic reviews of prevalence and risk factors are lacking. This study evaluated the prevalence and risk factors of thirst in critically ill patients. We conducted a comprehensive search of the MEDLINE, Cochrane Library, and CINAHL databases. The study design included cohort, cross-sectional, and intervention studies, including randomized and non-randomized controlled trials with control groups. The point estimates from each study were combined using a random-effects meta-analysis model. We aggregated the prevalence of thirst in ICU patients and calculated the point estimates and 95% confidence intervals. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool and Newcastle-Ottawa Scale. Fifteen studies were eligible for inclusion, of which seven reported the prevalence of thirst. A total of 2,204 patients were combined, with a prevalence estimate of 0.70. The risk factors for thirst were categorized as patient and treatment factors: four patient factors (e.g., serum sodium concentration and severity of illness) and six treatment factors (e.g., nil per os and use of diuretics) were identified. However, the results showed high heterogeneity in the prevalence of thirst among critically ill patients. It was established that 70% of critically ill patients experienced thirst. Additional investigations are required to obtain a more comprehensive overview of thirst among these patients. Systematic review registration number The protocol was registered in PROSPERO (ID: CRD42023428619) on June 6, 2023. (URL: https://www.crd.york.ac.uk )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan.
- Department of Adult Health Nursing, College of Nursing, Ibaraki Christian University, Hitachi, Ibaraki, Japan.
- College of Nursing, Kanto Gakuin University, Yokohama, Kanagawa, Japan.
- Department of Emergency and Critical Care Medicine, Hitachi General Hospital, Hitachi, Ibaraki, Japan.
- Department of Critical Care and Disaster Nursing, Japanese Red Cross Kyushu International College of Nursing, Munakata, Fukuoka, Japan.
ORCID-Profile: Takuto Fukunaga, Akira Ouchi, Gen Aikawa, Saiko Okamoto
Zitieren
APA
Fukunaga, T., Ouchi, A., Aikawa, G., Okamoto, S., Uno, S., & Sakuramoto, H. (2025). Prevalence, risk factors, and treatment methods of thirst in critically ill patients: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0315500
Vancouver
Fukunaga T, Ouchi A, Aikawa G, Okamoto S, Uno S, Sakuramoto H. Prevalence, risk factors, and treatment methods of thirst in critically ill patients: A systematic review and meta-analysis. PLOS ONE. 2025. doi:10.1371/journal.pone.0315500
BibTeX
@article{Fukunaga2025,
author = {Fukunaga, Takuto and Ouchi, Akira and Aikawa, Gen and Okamoto, Saiko and Uno, Shogo and Sakuramoto, Hideaki},
title = {Prevalence, risk factors, and treatment methods of thirst in critically ill patients: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0315500}
}
EUVIMED